Safety and Pharmacology Study of BMS-866949

NCT01124344 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

47

Enrollment

INDUSTRY

Sponsor class

Conditions

Major Depression

Interventions

DRUG: Placebo
DRUG: BMS-866949
DRUG: BMS-866949
DRUG: BMS-866949
DRUG: BMS-866949
DRUG: BMS-866949
DRUG: BMS-866949
DRUG: BMS-866949

Sponsor

Bristol-Myers Squibb